NEW YORK, May 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Bioinformatics Industry
http://www.reportlinker.com/p092468/Global-Bioinformatics-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics
This report analyzes the worldwide markets for Bioinformatics in US$ Million by following Product Segments: Software, Hardware, and Biocontent. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 206 companies including many key and niche players such as 3rd Millennium, Inc., Accelrys, Inc., Affymetrix, Inc., Agilent Technologies, Celera Group, Gene Logic, Geneva Bioinformatics S.A., IBM Life Sciences, ID Business Solutions Ltd., Instem Scientific Limited, Life Technologies Corporation, Kinexus Bioinformatics Corporation, and Nonlinear Dynamics Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-3
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Software I-4
Hardware I-4
Biocontent I-4
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW II-1
Revolution in Biology II-1
Increasing Role of Bioinformatics in Drug Discovery II-1
Rising Off-shoring of Bioinformatics Services II-2
Industry Structure II-2
Industry Challenges II-2
Consolidation - A Key to Success II-3
2. INTRODUCTION TO BIOINFORMATICS II-4
Bioinformatics Assumes More Comprehensive Role II-4
Bioinformatics: Definition II-4
Bioinformatics: History in Brief II-4
Functions of Bioinformatics II-5
Major End-Users of Bioinformatics II-5
Interface of IT and Biosciences II-6
Venture Capital and Bioinformatics II-6
Branches Associated with Bioinformatics II-6
Emerging Clinical Genomics Industry II-7
Genomic Business Models II-7
Applications of Bioinformatics II-7
Bioinformatics: Crucial for New Drug Development II-7
Application of Bioinformatics to Oral Genomics II-8
Importance of IP Protection Systems in Bioinformatics II-8
3. INSIGHT INTO BIOINFORMATICS TECHNOLOGY II-9
Protein Structure and its Determination II-9
Components of Bioinformatics II-9
Software II-9
Hardware II-9
Biocontent II-9
Proteins/ Proteomics Data and Databases II-9
DNA Sequences and Protein Sequencing II-10
Aligning Sequences II-10
Databases II-10
Nucleotide Databases II-10
EMBL Nucleotide Sequence Database II-10
DNA Database of Japan (DDBJ) II-11
GenBank II-11
Institute for Genomic Research (TIGR) II-11
Protein Databases II-12
SWISS-PROT II-12
TrEMBL II-12
IMGT/LIGM-DB II-12
PROSITE II-12
Design and Development of XML Bioinformatics Environment II-12
Biopolymer Markup Language (BioML) II-12
Bioinformatics Sequence Mark-Up Language - BSML II-13
Genome Annotation Markup Elements (GAME) II-13
Microarray Markup Language (MAML) II-13
Gene Expression Markup Language (GEML™) II-13
Hardware II-13
Technologies Involved II-13
Computer-Assisted Imaging, Mapping and High-Throughput
Screening II-13
Database Engineering II-14
Computer Processing II-14
Computational Software II-14
4. PRODUCT INNOVATIONS/INTRODUCTIONS II-15
Agilent Technologies Releases its New Version Software II-15
Qlucore Introduces New Bio-Informatics Software in Indian Market II-15
Amazon Web Services Unveils a New Web Service II-16
CollabRx Introduces New Cancer Research Service II-17
5. PRODUCT INNOVATIONS/INTRODUCTIONS A HISTORIC PERSPECTIVE BUILDER II-18
Spansion Releases its EcoRAM Solution Architecture II-18
Agilent Launches Agilent GeneSpring GX 10.0 Bioinformatics
Software II-18
GenomeQuest Introduces New On-Demand Informatics Solution II-19
Mitrionics Introduces FPGA Accelerator Kit in Partnership with
Nallatech II-19
REvolution Computing Rolls Out RPro™ II-20
eXludus Introduces SimpliGrid Software II-20
Accelrys Rolls Out Three New Component Collections for its
SciTegic Pipeline Pilot™ II-20
Agilent Technologies Unveils Gene Expression Bioinformatics
System, GeneSpring GX 9.0 II-21
GeneBio and SIB Roll Out New Version of Melanie 2-D Gel
Analysis Platform II-21
InforSense to Incorporate BioWisdom's SRS software in its
Workflow Analytics Platform II-21
BioWisdom Launches SRS 3D Technology, as a Free Software II-21
GeneGo Incorporates Cytoscape Software on its Data Analysis
Platform II-22
Applied Biosystems and Integromics Unveil Integrated Real-
Time PCR Data Analysis Solution II-22
Applied Biosystems Rolls Out Advanced DNA Sequencing Platform,
The SOLiD™ System II-22
GeneBio Introduces New Version of Phenyx Platform II-23
TCS to Introduce Enhanced Bioinformatics Software, BioAppliance II-23
Applied Biosystems Introduces Genotyping Service Provider Program II-23
Applied Biosystems Launches Variant Reporter™, Genetic
Variation Data Analysis Software II-23
GeneBio Launches Online Platform of Phenyx, PhenyxOnline. II-24
InforSense Rolls Out a Statistical Genetics Solution, GenSense II-24
U. S. Department of Energy Joint Genome Institute Introduces
IMG Version 2.1 II-24
CLC bio Launches CLC Bioinformatics Cell II-24
Accelrys Unveils Imaging Software for SciTegic Pipeline Pilot II-25
CLC bio Launches the Pioneering Customizable Bioinformatics Suite II-25
Jalaja Technologies and The Institute of Genomics &
Integrative Biology Devise GENO-CLUSTER Bioinformatics
Software II-25
CLC Bio Launches Four New Bioinformatics Software II-26
Insightful Develops Bioinformatics Software for National
Cancer Institute II-26
3rd Millennium Unveils 2.0 ARDAS™ Software II-26
GeneBio Introduces Phenyx 2.1 for Proteomics MS Data Analysis II-27
BioWisdom Unveils SRS 8.2 II-27
INCOGEN Releases Version 3.3 of VIBE Data Pipelining Software
for Bioinformatics II-27
INCOGEN Introduces VIBE 3.1 Bioinformatics Data Pipelining
Software II-27
InforSense Launches InforSense KDE, InforSense BioSense Grid
on Mac OS X V 10.4 II-28
Massively Parallel Technologies Completes Early Beta Testing
of Bioinformatics Tool II-28
Kinexus Announces Launch of KiNET Functional Proteomics Database II-28
Agilent Technologies Launches Search Tool for Cytoscape
Bioinformatics Platform II-28
6. RECENT INDUSTRY ACTIVITY II-29
Instem Takes Over BioWisdom II-29
Quest Diagnostics Acquires Celera Corp II-29
CLC bio Partners with Isilon Systems II-29
IDBS Takes Over InforSense II-30
Microsoft Acquires Rosetta Biosoftware II-30
Ambry and SoftGenetics Collaborate on Bioinformatics II-31
Aditi Inks Partnership Agreement with Microsoft BioIT II-32
GATC Biotech Collaborates with Complete Genomics on Genome
Sequencing II-32
Qiagen NV Announces Plans to Acquire SABiosciences II-33
Lonza Group Acquires AlgoNomics II-33
Cell Biosciences Acquires Alpha Innotech II-33
Columbia University Selects Force10 for Networking Services II-34
OSI Extends Collaboration Agreement with Aveo II-34
Microsoft to Acquire Rosetta Biosoftware II-35
Epistem and Novartis Collaborate II-35
Avesthagen Inks JV Agreement with Uxmal II-36
The HDF Group and Geospiza Secure NHGRI Grant II-36
Eureka Genomics and Nanobac Pharmaceuticals to Merge II-37
7. STRATEGIC CORPORATE DEVELOPMENTS A HISTORIC PERSPECTIVE BUILDER II-38
GenoLogics Inks Supply Deal with Pfizer for Informatics Solutions II-38
Sequenom Completes Acquisition of Michigan based CLIA-
Certified Laboratory II-38
Proxeon and GeneBio Enter Agreement for ProteinCenter and Phenyx II-39
CSC Secures Contract for Providing Data Management Services
and IT to the FDA II-39
Rosetta Genomics Acquires Parkway Clinical Laboratories II-39
BIOBASE Inaugurates New Japanese Subsidiary, Nihon BIOBASE KK II-40
Nanobac Pharmaceuticals Signs LoI to Acquire DNAPrint Genomics II-40
InforSense and Crosslinks Ink Research Alliance II-40
Chemizon and KRIBB Team Up to establish a New Biotech Company II-41
BIOBASE Establishes a New Japanese Subsidiary, Nihon BIOBASE KK II-41
Applied Biosystems Ropes in Geospiza® and Genome Quest into
Software Development Community for Developing Advanced
Bioinformatics Tools II-41
InforSense and BioWisdom Enter Bioinformatics Agreement II-41
Merck Acquires Minority Interest in High Throughput Genomics II-42
NYLIC Acquires Minority Interest in Avestha Gengraine
Technologies II-42
Tripos Divests Discovery Informatics Business Assets to Vector
Capital II-42
Gene Logic Completes Sale of Genomic Assets to Ocimum
Biosolutions II-43
SGI Develops World's Largest FPGA Supercomputer II-43
Progeniq Enrolls into BioIT Alliance II-43
Applied Biosystems Launches Software Development Community for
Advancing Bioinformatics Applications for its SOLiD™ System II-43
Agilent and Strand Life Sciences Ink Software Development
Agreement II-43
Cell Therapeutics to Acquire Systems Medicine II-44
SGI Enrolls into Bio-IT Alliance II-44
GenoLogic Joins Illumina's Bioinformatics Program, Illumina
Connect II-44
InApp Software to Establish a Bioinformatics Society in India II-44
Agilent Technologies Partners with Gene Logic for Research and
iscovery Projects II-45
Thomson, Corp. Acquires Unleashed Informatics II-45
iHorizons Signs R&D Agreement With AREA Science Park and
Cluster in Biomedicine II-45
GeneBio's Software to be Integrated into Biozentrum's
Proteomics Cluster II-46
BioWisdom Signs Agreement with the European Bioinformatics
Institute to Deliver SRS 8.2 II-46
Genencor Licenses ERGO™ Software to Integrated Genomics II-46
Intelligent Business Systems Signs MOU to Establish a
Biotechnology Solutions Venture in India II-47
Nonlinear Dynamics and Agilent Sign Co-Marketing Deal II-47
Agilent Technologies' Bioinformatics Solution Enables
Platforms' Standardization at NCI II-47
LION Bioscience Divests Bioinformatics Business to BioWisdom II-48
Applied Biosystems Collaborates with GeneGo II-48
BioWisdom and AstraZeneca Extend Partnership for Intelligence
Networks II-49
BioWisdom Extends SRS Licenses for Boehringer Ingelheim II-49
Sheba and Weizmann Attain Licenses for Partek's Genomics Suite
Software II-49
Sirna Gains Exclusive Worldwide License for miRNA Technology II-49
HSARPA to Commence Bioinformatics and Assay Development Programme II-50
Syngenta Selects InforSense® to Develop Bioinformatics
Computational Platform II-50
Stratagene Partners with Strand Life Sciences for Advanced
Bioinformatics Software Tools II-50
Nonlinear Dynamics Join Forces with Genedata Over Proteomics
Research II-50
RTI International Bags Bioinformatics Contracts from the
National Institutes of Health's NCI II-51
Cold Spring Harbor Lab Kicks off Bioinformatics Expansion II-51
Iowa State Bags $3 Million IGERT Grant for Bioinformatics II-51
AMITY, MASCON Announce Partnership for Bioinformatics R&D II-51
BioTeam Teams Up InforSense to Develop Grid Computing
Environment for Bioinformatics II-51
Nonlinear and Water Corp Ink Agreement II-51
Clarient Signs Bioinformatics Patent Licensing Agreement With HDC II-52
Gene-IT to Develop Bioinformatics Technology II-52
AstraZeneca Purchases License for Target Informatics Platform
from Eidogen-Sertanty II-52
SRI International Expands BioCyc Database Collection II-52
8. FOCUS ON SELECT PLAYERS II-53
3rd Millennium, Inc. (US) II-53
Accelrys, Inc. (US) II-53
Affymetrix, Inc. (US) II-53
Agilent Technologies (US) II-54
Celera Group (US) II-54
Gene Logic (US) II-54
Geneva Bioinformatics S.A (Switzerland) II-55
IBM Life Sciences (US) II-55
ID Business Solutions Ltd. (UK) II-55
Instem Scientific Limited (Formerly BioWisdom, Ltd.) (UK) II-56
Life Technologies Corporation (US) II-56
Kinexus Bioinformatics Corporation (Canada) II-57
Nonlinear Dynamics, Ltd. (UK) II-57
9. GLOBAL MARKET PERSPECTIVE II-58
Table 1: World Recent Past, Current & Future Market Analysis
for Bioinformatics by Geographic Region US, Canada, Japan,
Europe, Asia-Pacific and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2009 through 2017 (includes corresponding Graph/Chart) II-58
Table 2: World Historic Review for Bioinformatics by
Geographic Region US, Canada, Japan, Europe, Asia- Pacific and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-59
Table 3: World 15-Year Perspective for Bioinformatics by
Geographic Region Percentage Breakdown of Dollar Sales for US,
Canada, Japan, Europe, Asia-Pacific and Rest of World for
Years 2003, 2011 & 2017 (includes corresponding Graph/Chart) II-60
Analytics by Product Segment II-61
Table 4: World Recent Past, Current & Future Market Analysis
for Software (Bioinformatics) by Geographic Region US, Canada,
Japan, Europe, Asia-Pacific and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2009 through 2017 (includes corresponding
Graph/Chart) II-61
Table 5: World Historic Review for Software (Bioinformatics)
by Geographic Region US, Canada, Japan, Europe, Asia-Pacific
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2003 through 2008
(includes corresponding Graph/Chart) II-62
Table 6: World 15-Year Perspective for Software
(Bioinformatics) by Geographic Region Percentage Breakdown of
Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific and
Rest of World for Years 2003, 2011 & 2017 (includes
corresponding Graph/Chart) II-63
Table 7: World Recent Past, Current & Future Market Analysis
for Biocontent (Bioinformatics) by Geographic Region US,
Canada, Japan, Europe, Asia-Pacific and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2009 through 2017 (includes corresponding
Graph/Chart) II-64
Table 8: World Historic Review for Biocontent (Bioinformatics)
by Geographic Region US, Canada, Japan, Europe, Asia-Pacific
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2003 through 2008
(includes corresponding Graph/Chart) II-65
Table 9: World 15-Year Perspective for Biocontent
(Bioinformatics) by Geographic Region Percentage Breakdown of
Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific and
Rest of World for Years 2003, 2011 & 2017 (includes
corresponding Graph/Chart) II-66
Table 10: World Recent Past, Current & Future Market Analysis
for Hardware (Bioinformatics) by Geographic Region US, Canada,
Japan, Europe, Asia-Pacific and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2009 through 2017 (includes corresponding
Graph/Chart) II-67
Table 11: World Historic Review for Hardware (Bioinformatics)
by Geographic Region US, Canada, Japan, Europe, Asia-Pacific
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2003 through 2008
(includes corresponding Graph/Chart) II-68
Table 12: World 15-Year Perspective for Hardware
(Bioinformatics) by Geographic Region Percentage Breakdown of
Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific and
Rest of World for Years 2003, 2011 & 2017 (includes
corresponding Graph/Chart) II-69
III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Market Overview III-1
Patents in Bioinformatics III-1
B.Market Analytics III-2
Table 13: The US Recent Past, Current & Future Market
Analysis for Bioinformatics by Product Segment Software,
Biocontent and Hardware Markets IndependentlyAnalyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) III-2
Table 14: The US Historic Review for Bioinformatics by
Product Segment Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-3
Table 15: The US 15-Year Perspective for Bioinformatics by
Product Segment Percentage Breakdown of Dollar Sales for
Software, Biocontent and Hardware Markets for Years 2003,
2011 & 2017 (includes corresponding Graph/Chart) III-4
2. CANADA III-5
A.Market Analysis III-5
Bioinformatics in Recombinant Technology III-5
Canadian Bioinformatics Industry III-5
B.Market Analytics III-6
Table 16: Canadian Recent Past, Current & Future Market
Analysis for Bioinformatics by Product Segment Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) III-6
Table 17: Canadian Historic Review for Bioinformatics by
Product Segment Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-7
Table 18: Canadian 15-Year Perspective for Bioinformatics by
Product Segment Percentage Breakdown of Dollar Sales for
Software Biocontent and Hardware Markets for Years 2003,
2011 & 2017 (includes corresponding Graph/Chart) III-8
3. JAPAN III-9
A.Market Analysis III-9
An Update on Japanese Bioinformatics Industry III-9
JbiC Drives Japanese Bioinformatics Industry III-9
B.Market Analytics III-10
Table 19: Japanese Recent Past, Current & Future Market
Analysis for Bioinformatics by Product Segment Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) III-10
Table 20: Japanese Historic Review for Bioinformatics by
Product Segment Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-11
Table 21: Japanese 15-Year Perspective for Bioinformatics by
Product Segment Percentage Breakdown of Dollar Sales for
Software, Biocontent and Hardware Markets for Years 2003,
2011 & 2017 (includes corresponding Graph/Chart) III-12
4. EUROPE III-13
A.Market Analysis III-13
European Bioinformatics Market III-13
Major Public Science Institutes III-13
Regulatory Environment III-13
B.Market Analytics III-14
Table 22: European Recent Past, Current & Future Market
Analysis for Bioinformatics by Geographic Region -France,
Germany, Italy, UK and Rest of Europe Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) III-14
Table 23: European Historic Review for Bioinformatics by
Geographic Region -France, Germany, Italy, UK and Rest of
Europe Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) III-15
Table 24: European 15-Year Perspective for Bioinformatics by
Geographic Region Percentage Breakdown of Dollar Sales for
France, Germany, UK, Italy and Rest of Europe for Years
2003, 2011 & 2017 (includes corresponding Graph/Chart) III-16
Table 25: European Recent Past, Current & Future Market
Analysis for Bioinformatics by Product Segment Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) III-17
Table 26: European Historic Review for Bioinformatics by
Product Segment Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-18
Table 27: European 15-Year Perspective for Bioinformatics by
Product Segment Percentage Breakdown of Dollar Sales for
Software, Biocontent and Hardware Markets for Years 2003,
2011 & 2017 (includes corresponding Graph/Chart) III-19
4a. FRANCE III-20
Market Analytics III-20
Table 28: French Recent Past, Current & Future Market
Analysis for Bioinformatics by Product Segments Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) III-20
Table 29: French Historic Review for Bioinformatics by
Product Segment Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-21
Table 30: French 15-Year Perspective for Bioinformatics by
Product Segment Percentage Breakdown of Dollar Sales for
Software, Biocontent and Hardware Markets for Years 2003,
2011 & 2017 (includes corresponding Graph/Chart) III-22
4b. GERMANY III-23
Market Analysis III-23
Table 31: German Recent Past, Current & Future Market
Analysis for Bioinformatics by Product Segments -Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) III-23
Table 32: German Historic Review for Bioinformatics by
Product Segment Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-24
Table 33: German 15-Year Perspective for Bioinformatics by
Product Segment Percentage Breakdown of Dollar Sales for
Software, Biocontent and Hardware Markets for Years 2003,
2011 & 2017 (includes corresponding Graph/Chart) III-25
4c. ITALY III-26
Market Analytics III-26
Table 34: Italian Recent Past, Current & Future Market
Analysis for Bioinformatics by Product Segments - Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) III-26
Table 35: Italian Historic Review for Bioinformatics by
Product Segment Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-27
Table 36: Italian 15-Year Perspective for Bioinformatics by
Product Segment Percentage Breakdown of Dollar Sales for
Software, Biocontent and Hardware Markets for Years 2003,
2011 & 2017 (includes corresponding Graph/Chart) III-28
4d. THE UNITED KINGDOM III-29
A.Market Analysis III-29
Research Entities III-29
B.Market Analytics III-30
Table 37: The UK Recent Past, Current & Future Market
Analysis for Bioinformatics by Product Segment Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) III-30
Table 38: The UK Historic Review for Bioinformatics by
Product Segment Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-31
Table 39: The UK 15-Year Perspective for Bioinformatics by
Product Segment Percentage Breakdown of Dollar Sales for
Software, Biocontent and Hardware Markets for Years 2003,
2011 & 2017 (includes corresponding Graph/Chart) III-32
4e. REST OF EUROPE III-33
A.Market Analysis III-33
National Service Center for Bioinformatics in Netherlands III-33
B.Market Analytics III-33
Table 40: Rest of European Market for Bioinformatics by
Product Segment Recent Past, Current & Future Analysis for
Software, Biocontent and Hardware Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2009 through 2017 (includes corresponding Graph/Chart) III-33
Table 41: Rest of European Historic Review for
Bioinformatics by Product Segment Software, Biocontent and
Hardware Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) III-34
Table 42: Rest of European 15-Year Perspective for
Bioinformatics by Product Segment Percentage Breakdown of
Dollar Sales for Software, Biocontent and Hardware Markets
for Years 2003, 2011 & 2017 (includes corresponding
Graph/Chart) III-35
5. ASIA-PACIFIC III-36
A.Market Analysis III-36
Bioinformatics in Asia-Pacific III-36
India III-36
India - An Emerging Player in Bioinformatics Offshoring
Services III-37
Emerging Trends in the Indian Bioinformatics Services Sector III-37
Taiwan III-38
Australia III-38
Market Drivers III-38
Market Inhibitors III-39
Singapore III-39
Korea III-39
B.Market Analytics III-40
Table 43: Asia-Pacific Market for Bioinformatics by Product
Segment Recent Past, Current & Future Analysis for Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) III-40
Table 44: Asia-Pacific Historic Review for Bioinformatics by
Product Segment Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-41
Table 45: Asia-Pacific 15-Year Perspective for
Bioinformatics by Product Segment Percentage Breakdown of
Dollar Sales for Software, Biocontent and Hardware Markets
for Years 2003, 2011 & 2017 (includes corresponding
Graph/Chart) III-42
6. REST OF WORLD III-43
Market Analytics III-43
Table 46: Rest of World Market for Bioinformatics by Product
Segment Recent Past, Current & Future Analysis for Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) III-43
Table 47: Rest of World Historic Review for Bioinformatics
by Product Segment Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-44
Table 48: Rest of World 15-Year Perspective for
Bioinformatics by Product Segment Percentage Breakdown of
Dollar Sales for Software, Biocontent and Hardware Markets
for Years 2003, 2011 & 2017 (includes corresponding
Graph/Chart) III-45
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 206 (including Divisions/Subsidiaries - 218)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 146
Canada 9
Japan 2
Europe 46
France 2
Germany 14
The United Kingdom 12
Spain 1
Rest of Europe 17
Asia-Pacific (Excluding Japan) 12
Africa 1
Middle-East 2
------------------------------------------
To order this report:
Genomics Industry: Global Bioinformatics Industry
Check our Industry Analysis and Insights
CONTACT:
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article